Giglio, Rosaria Vincenza
 Distribuzione geografica
Continente #
NA - Nord America 3.772
EU - Europa 2.455
AS - Asia 856
SA - Sud America 211
AF - Africa 39
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.347
Nazione #
US - Stati Uniti d'America 3.743
IT - Italia 1.615
SG - Singapore 414
CN - Cina 246
DE - Germania 193
BR - Brasile 171
GB - Regno Unito 122
FI - Finlandia 102
IE - Irlanda 79
SE - Svezia 51
IN - India 41
FR - Francia 39
RU - Federazione Russa 38
RO - Romania 35
AT - Austria 31
UA - Ucraina 28
HK - Hong Kong 27
NL - Olanda 23
ES - Italia 19
TR - Turchia 19
BE - Belgio 16
IR - Iran 16
EG - Egitto 15
AR - Argentina 12
CA - Canada 12
KR - Corea 12
JP - Giappone 11
MX - Messico 11
UZ - Uzbekistan 11
BG - Bulgaria 10
CH - Svizzera 9
IL - Israele 8
NZ - Nuova Zelanda 8
BO - Bolivia 7
CI - Costa d'Avorio 7
BD - Bangladesh 6
MA - Marocco 6
PL - Polonia 6
CL - Cile 5
CO - Colombia 5
CZ - Repubblica Ceca 5
ID - Indonesia 5
PK - Pakistan 5
SA - Arabia Saudita 5
VN - Vietnam 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
DK - Danimarca 4
GR - Grecia 4
IQ - Iraq 4
KE - Kenya 4
MY - Malesia 4
PT - Portogallo 4
VE - Venezuela 4
AU - Australia 3
AZ - Azerbaigian 3
ET - Etiopia 3
NP - Nepal 3
PH - Filippine 3
RS - Serbia 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EE - Estonia 2
HN - Honduras 2
HU - Ungheria 2
LU - Lussemburgo 2
ME - Montenegro 2
PE - Perù 2
TN - Tunisia 2
BH - Bahrain 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
GT - Guatemala 1
IM - Isola di Man 1
LB - Libano 1
LT - Lituania 1
MC - Monaco 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PY - Paraguay 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 7.347
Città #
Fairfield 493
Chandler 477
Ashburn 328
Singapore 308
Palermo 249
Wilmington 220
Seattle 190
Houston 184
Woodbridge 177
Cambridge 176
Ann Arbor 120
Medford 101
Des Moines 96
Rome 82
Altamura 76
Milan 74
Dublin 73
Princeton 66
San Diego 63
Lawrence 62
New York 48
Santa Clara 41
London 36
Nuremberg 34
Boardman 30
Ludwigshafen am Rhein 30
Venice 29
Helsinki 27
Nanjing 27
Redwood City 21
Falls Church 20
Lappeenranta 20
Pune 20
San Paolo di Civitate 20
Hong Kong 19
Naples 18
Florence 17
The Dalles 17
Bremen 16
Jinan 16
Napoli 16
Bari 15
Cagliari 15
São Paulo 15
Alcamo 14
Beijing 14
Brussels 14
Changsha 14
Dearborn 14
Hebei 14
Nanchang 14
Shenyang 14
Vienna 14
Turin 13
Falkenstein 12
Padova 12
Al Mansurah 11
Kilburn 11
Los Angeles 11
Munich 11
Pisa 11
Catania 10
Chicago 10
Edinburgh 10
Tianjin 10
Tulsa 10
Amsterdam 9
Ningbo 9
Verona 9
Columbus 8
Dallas 8
Istanbul 8
Jacksonville 8
Sandston 8
Tashkent 8
Abidjan 7
Bologna 7
Constanta 7
Moscow 7
Sofia 7
Zhengzhou 7
Aversa 6
Bergamo 6
Brooklyn 6
Central 6
Durham 6
Genoa 6
Gwangmyeong 6
Lozzo di Cadore 6
Madrid 6
Miami 6
Mistretta 6
West Jordan 6
Aragona 5
Azor 5
Brolo 5
Buenos Aires 5
Castrovillari 5
Foggia 5
Frankfurt am Main 5
Totale 4.674
Nome #
PROBIOTICI E TERAPIA CONVENZIONALE: NUOVE FRONTIERE NELLA GESTIONE DELLE MANIFESTAZIONI ARTICOLARI DELLE MALATTIE INFIAMMATORIE INTESTINALI (IBD) 763
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 205
Monocyte distribution width (MDW) as a screening tool for sepsis in the Emergency Department 185
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. 177
Management of Statin Intolerance in 2018: Still More Questions Than Answers 162
The Role of Nutraceuticals in Statin Intolerant Patients 156
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 155
The effect of bergamot on dyslipidemia 155
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 153
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 147
Serum low density lipoprotein subclasses in asthma 135
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 135
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods 127
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 124
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 119
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 114
Reference interval of monocyte distribution width (MDW) in healthy blood donors 111
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. 107
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 107
A new tool for sepsis screening in the Emergency Department 105
Serum lipoproteins are not associated with the severity of asthma 102
Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG 101
Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis 98
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 98
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici 97
Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis 96
Nutraceuticals as an important part of combination therapy in dyslipidaemia 90
Monocyte distribution width as a biomarker of sepsis in the intensive care unit: A pilot study 88
Vitamin D and Multiple Sclerosis: An Open-Ended Story 87
Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19 87
Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins Be Key Mediators Of This Association? 86
Presepsin and Midregional Proadrenomedullin in Pediatric Oncologic Patients with Febrile Neutropenia 86
Advances in pharmacological treatment of type 1 diabetes during pregnancy 85
Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study 84
NUOVE STRATEGIE TERAPEUTICHE E DIAGNOSTICHE PER IL MANAGEMENT DEL RISCHIO CARDIO-METABOLICO IN PAZIENTI CON NAFLD CON O SENZA DIABETE MELLITO TIPO 2 84
Evaluation of anti-sars-cov-2 s-rbd igg antibodies after covid-19 mrna bnt162b2 vaccine 82
Preliminary results of citraves™ effects on low density lipoprotein cholesterol and waist circumference in healthy subjects after 12 weeks: A pilot open-label study 81
Comparative analysis of biochip mosaic-based indirect immunofluorescence with enzyme-linked immunosorbent assay for diagnosing myasthenia gravis 79
Lipid subclasses profiles and oxidative stress in aggressive periodontitis before and after treatment 78
Future perspectives of the pharmacological management of diabetic dyslipidemia 77
Foxp3 and gata3 polymorphisms, vitamin d3 and multiple sclerosis 76
Effect of liraglutide on carotid intima-media thickness in patients with type-2 diabetes: a 4-month prospective study 75
Prognostic Role of CSF β-amyloid 1-42/1-40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis 74
Monocyte distribution width (MDW) as a reliable biomarker for urosepsis 73
Effects of liraglutide on plasma ghrelin concentrations and oxidative stress in patients with type 2 diabetes: a 2-month prospective pilot study. 71
Natural approaches in metabolic syndrome management 71
The role of serum free light chain as biomarker of Myasthenia Gravis 70
COVID-19 and Alzheimer's Disease 69
Polyphenols: Potential use in the prevention and treatment of cardiovascular diseases 68
Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis 67
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 66
The Value of a Complete Blood Count (CBC) for Sepsis Diagnosis and Prognosis 65
A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes. 63
Pharmacotherapy for gestational diabetes 63
Time-dependent stability of monocyte distribution width (MDW) 61
Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas? 61
Validation of monocyte distribution width decisional cutoff for sepsis detection in the acute setting 61
Monocyte distribution width (MDW) as a screening tool for early detecting sepsis: a systematic review and meta-analysis 61
The role of vitamin d as a biomarker in alzheimer’s disease 59
Independent validation of sepsis index for sepsis screening in the emergency department 58
Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer's Disease from Other Neurological Disorders 57
Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders 55
FIBROSIS DIAGNOSTIC SCORES VALIDATION IN OBESE PATIENTS WITH NON-ALCOHOLIC LIVER DISEASE 55
Recent Updates and Advances in the Use of Glycated Albumin for the Diagnosis and Monitoring of Diabetes and Renal, Cerebro- and Cardio-Metabolic Diseases 55
Preliminary reference intervals of Glycated Albumin in healthy Caucasian pregnant women 53
Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease 53
Novel therapeutical approaches to managing atherosclerotic risk 51
Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases 48
Diabetes and colorectal cancer risk: A new look at molecular mechanisms and potential role of novel antidiabetic agents 48
Impact of Mycobacterium tuberculosis Infection on Human B Cell Compartment and Antibody Responses 48
Role of Multiple Vitamin D-Related Polymorphisms in Multiple Sclerosis Severity: Preliminary Findings 44
Monocyte Distribution Width (MDW) as a biomarker of sepsis: An evidenced-based laboratory medicine approach 42
Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population 39
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes 39
Thrombocytopenia and hyperinflammation are induced by extracellular histones circulating in blood 38
Monocyte distribution width (MDW) kinetic for monitoring sepsis in intensive care unit 38
Evaluation of core Biomarkers of Alzheimer’s disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform 37
Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus 35
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 35
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 34
Monocyte distribution width kinetic after surgery 34
The Role of TAR DNA Binding Protein 43 (TDP-43) as a CandiDate Biomarker of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis 34
Circulating histones contribute to monocyte and MDW alterations as common mediators in classical and COVID-19 sepsis 32
Validation of glycated albumin reference interval in healthy Caucasian pregnant women 32
Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes 31
Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine 30
Multiple Sclerosis Pathogenesis: Possible Interplay between Vitamin D Status and Epstein Barr Virus Infection 29
Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis 28
Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes 28
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies 26
Evaluation of the analytical performance of three chemiluminescence serological assays for detecting anti-SARS-CoV-2 antibodies 24
Monocyte distribution width alterations and cytokine storm are modulated by circulating histones 23
Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update 22
Microglial Activation and Priming in Alzheimer’s Disease: State of the Art and Future Perspectives 22
Microglial Activation and Priming in Alzheimer’s Disease: State of the Art and Future Perspectives 19
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes 19
What is the impact of circulating histones in COVID-19: a systematic review 19
Genetic and Epigenetic Biomarkers For Diagnosis, Prognosis and Treatment Of Metabolic Syndrome 17
The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance 16
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review. 14
Totale 7.943
Categoria #
all - tutte 40.936
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.936


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020174 0 0 0 0 0 0 0 0 0 33 110 31
2020/20211.153 24 24 115 255 138 49 42 98 126 130 78 74
2021/20221.201 64 126 124 52 44 76 50 118 107 153 115 172
2022/20231.793 135 278 56 172 143 276 137 153 199 50 112 82
2023/2024985 39 97 80 68 62 156 173 55 39 49 49 118
2024/20251.474 52 190 127 182 92 112 201 130 155 233 0 0
Totale 7.967